» Articles » PMID: 35581125

Clinical Significance of Chest CT for the Exclusion of COVID-19 in Pre-admission Screening: Is It Worthwhile Using Chest CT with Reverse-transcription Polymerase Chain Reaction Test?

Overview
Journal Respir Investig
Publisher Elsevier
Date 2022 May 17
PMID 35581125
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A single reverse-transcription polymerase chain reaction (RT-PCR) test is not sufficient to exclude COVID-19 in hospital pre-admission screening. However, repeated RT-PCR tests are time-consuming. This study investigates the utility of chest computed tomography (CT) for COVID-19 screening in asymptomatic patients.

Methods: Between April 2020 and March 2021, RT-PCR testing and chest CT were performed to screen COVID-19 in 10 823 asymptomatic patients prior to admission. Chest CT findings were retrospectively evaluated using the reporting system of the Radiological Society of North America. Using RT-PCR results as a reference, we assessed the diagnostic efficacy of chest CT during both the low- and high-prevalence periods of the COVID-19 pandemic.

Results: Following a positive RT-PCR test, 20 asymptomatic patients (0.18%) were diagnosed with COVID-19; in the low-prevalence period, 5 of 6556 patients (0.076%) were positive; and in the high-prevalence period, 15 of 4267 patients (0.35%) were positive. Of the 20 asymptomatic COVID-19 positive patients, chest CT results were positive for COVID-19 pneumonia in 8 patients. Chest CT results were false-positive in 185 patients (1.7% false-positive rate, and 60% false-negative rate). Pneumonia that was classified as a "typical appearance" of COVID-19 reported as false-positives in 36 of 39 patients (92.3%). Across the study period, the diagnostic efficacy of "typical appearance" on chest CT were characterized by a sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of 15%, 99.7%, 99.7%, 7.7%, and 99.8%; 20%, 99.6%, 99.6%, 4%, and 99.9%; and 13.3%, 99.7%, 99.7%, 14.3%, and 99.7%, in the entire study, low-, and high-prevalence periods, respectively.

Conclusions: Addition of chest CT to RT-PCR testing provides no benefit to the detection of COVID-19 in asymptomatic patients.

Citing Articles

Neck CT angiography in acute stroke: An open window for fast detection of COVID-19 lung involvement? Applicability in telemedicine.

Ucles J, Cuesta E, Rigual R, Rodriguez-Pardo J, Ruiz-Ares G, Navia P PLoS One. 2023; 18(2):e0281955.

PMID: 36827270 PMC: 9955938. DOI: 10.1371/journal.pone.0281955.

References
1.
Abdolrahimzadeh Fard H, Mahmudi-Azer S, Sefidbakht S, Iranpour P, Bolandparvaz S, Abbasi H . Evaluation of Chest CT Scan as a Screening and Diagnostic Tool in Trauma Patients with Coronavirus Disease 2019 (COVID-19): A Cross-Sectional Study. Emerg Med Int. 2021; 2021:4188178. PMC: 8245252. DOI: 10.1155/2021/4188178. View

2.
Himoto Y, Sakata A, Kirita M, Hiroi T, Kobayashi K, Kubo K . Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan. Jpn J Radiol. 2020; 38(5):400-406. PMC: 7105967. DOI: 10.1007/s11604-020-00958-w. View

3.
Rossi S, Erasmus J, McAdams H, Sporn T, Goodman P . Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000; 20(5):1245-59. DOI: 10.1148/radiographics.20.5.g00se081245. View

4.
Chetan M, Tsakok M, Shaw R, Xie C, Watson R, Wing L . Chest CT screening for COVID-19 in elective and emergency surgical patients: experience from a UK tertiary centre. Clin Radiol. 2020; 75(8):599-605. PMC: 7301066. DOI: 10.1016/j.crad.2020.06.006. View

5.
Inui S, Kurokawa R, Nakai Y, Watanabe Y, Kurokawa M, Sakurai K . Comparison of Chest CT Grading Systems in Coronavirus Disease 2019 (COVID-19) Pneumonia. Radiol Cardiothorac Imaging. 2021; 2(6):e200492. PMC: 7650298. DOI: 10.1148/ryct.2020200492. View